Abstract:The currently used coronary artery bypass graft predictive models, although generally accurate, have significant shortcomings and should be used with caution. The predicted mortality rate following coronary artery bypass graft surgery varied by a factor of 3.3 from lowest to highest, making the choice of model a critical factor when assessing outcome. The use of these models for individual patient risk estimations is risky because of the marked discrepancies in individual predictions created by each model.
“…The area under the ROC curve in our population for the NNE model (0.772) is slightly higher than reported by O'Conner (0.76), 5 Peterson (0.72), 15 or Orr (0.72). 16 In our population, the C-statistic for the PA model was 0.752. The largest PA C-statistics have been reported by Martinez-Alario at a tertiary referral center 12 and Pilam from the San Francisco Heart Institute 11 as 0.857 and 0.80, respectively, whereas the lowest values were reported by Weightman 9 and Pons from a tertiary cardiac center 32 of 0.70 and 0.67, respectively.…”
Section: Discussionmentioning
confidence: 71%
“…Pilam 11 also reported the highest C-statistic for the CL model (0.80), whereas both Weightman 9 and Pons 32 reported their CL C-statistic of 0.68. The NY C-statistics range from 0.72 15,16 to 0.787 4 and the CA C-statistics range from 0.60 to 0.755. 3,[9][10][11]15,16,32,33 These mortality models may be used to conduct comparisons of risk-adjusted cardiac surgical outcomes among adult cardiac surgical institutions.…”
Section: Discussionmentioning
confidence: 99%
“…Because patient populations differ significantly between institutions and countries, it is intuitively evident that comparison of absolute mortality rates are not justified. 1,3,16,31 These risk-adjusted indices were developed to correct for differences in patient population and allow for comparison of actual outcome to predicted outcome. There are key differences between models in the patient population from which these models were derived and validated, in the number and type of institutions involved, and in whether the data were retrospective or prospective.…”
Section: Discussionmentioning
confidence: 99%
“…The NY index has been used extensively and has performed well as an external benchmark, an algorithm developed in 1 population and applied to the evaluation population, in subsequent analyses. [15][16][17] We used the 14-variable mortality model and multivariate odds ratios as given in Table 1. 17 The NNE study group model was developed using data from 3055 patients from 5 clinical centers.…”
Section: Bypass Surgery Risk-adjusted Modelsmentioning
“…The area under the ROC curve in our population for the NNE model (0.772) is slightly higher than reported by O'Conner (0.76), 5 Peterson (0.72), 15 or Orr (0.72). 16 In our population, the C-statistic for the PA model was 0.752. The largest PA C-statistics have been reported by Martinez-Alario at a tertiary referral center 12 and Pilam from the San Francisco Heart Institute 11 as 0.857 and 0.80, respectively, whereas the lowest values were reported by Weightman 9 and Pons from a tertiary cardiac center 32 of 0.70 and 0.67, respectively.…”
Section: Discussionmentioning
confidence: 71%
“…Pilam 11 also reported the highest C-statistic for the CL model (0.80), whereas both Weightman 9 and Pons 32 reported their CL C-statistic of 0.68. The NY C-statistics range from 0.72 15,16 to 0.787 4 and the CA C-statistics range from 0.60 to 0.755. 3,[9][10][11]15,16,32,33 These mortality models may be used to conduct comparisons of risk-adjusted cardiac surgical outcomes among adult cardiac surgical institutions.…”
Section: Discussionmentioning
confidence: 99%
“…Because patient populations differ significantly between institutions and countries, it is intuitively evident that comparison of absolute mortality rates are not justified. 1,3,16,31 These risk-adjusted indices were developed to correct for differences in patient population and allow for comparison of actual outcome to predicted outcome. There are key differences between models in the patient population from which these models were derived and validated, in the number and type of institutions involved, and in whether the data were retrospective or prospective.…”
Section: Discussionmentioning
confidence: 99%
“…The NY index has been used extensively and has performed well as an external benchmark, an algorithm developed in 1 population and applied to the evaluation population, in subsequent analyses. [15][16][17] We used the 14-variable mortality model and multivariate odds ratios as given in Table 1. 17 The NNE study group model was developed using data from 3055 patients from 5 clinical centers.…”
Section: Bypass Surgery Risk-adjusted Modelsmentioning
“…In order to assess their appropriateness in different clinical settings these models were often applied to surgical procedures for which they were not originally designed [9][10][11][12][13]. The overall conclusion was that the tested models are generally accurate and perform a useful service, but their applicability to different health systems cannot be warranted.…”
Although this analysis reveals a satisfactory concordance between results from the three models, a detailed comparison shows that the Italian CABG model uses fewer variables and performs better than the others. Nevertheless, when properly recalibrated, the EuroSCORE model can be exported to the Italian population and used to rank hospital performance and evaluate preoperative risk of patients undergoing open-heart surgery.
To compare the performance of several riskscoring models to predict surgical mortality following open heart surgery. Design: A prospective observational study. Setting: Seven tertiary cardiac centers (3 private and 4 public and teaching hospitals) in Catalonia (Spain).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.